Connect with us

Media OutReach

Uni-Bio Science Joins Forces with WMU NERC and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout

Published

on

HONG KONG SAR – EQS Newswire – 30 December 2025 – Uni-Bio Science Group Limited (“Uni-Bio Science Group”, “Uni-Bio” or “the Group”) is pleased to announce the official signing of a tripartite strategic cooperation agreement in Wenzhou, Zhejiang, with the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University (“WMU NERC”) and the People’s Government of Ouhai District, Wenzhou. The parties also explored the subsequent co-establishment of the “Uni-Bio – WMU Joint Innovation Laboratory for Translational Medicine.” This collaboration marks a key step for Uni-Bio in deeply integrating with a national-level research platform and a regional industrial ecosystem. Through a synergistic “government-university-enterprise” model, the three parties will focus on the core regenerative medicine field of growth factors to establish an end-to-end innovation system spanning basic research, clinical translation, and industrial application. This represents a milestone for the Group in consolidating its R&D pipeline and accelerating its strategic execution.

Strategic cooperation signing ceremony group photo

Focusing on Growth Factor Frontiers, Unleashing “1+1>2” Clinical and Market Potential

Growth factors are key signaling molecules that regulate cell proliferation, migration, and tissue repair, representing some of the most transformative bioactive substances in regenerative medicine. Both EGF (Epidermal Growth Factor) and FGF (Fibroblast Growth Factor) have demonstrated significant efficacy across major indications, including wound healing, ophthalmic diseases, and metabolic disorders, underscoring their substantial market potential.

Uni-Bio possesses deep expertise in the EGF field, with its flagship products GeneTime® and GeneSoft® achieving large-scale production and nationwide commercial coverage. Concurrently, under the leadership of Academician Li Xiaokun, the WMU NERC has been a global pioneer in FGF drug R&D, having successfully translated several Class I New Drugs – including Recombinant Human Basic Fibroblast Growth Factor – and has accumulated substantial clinical data and authoritative expert consensus in trauma and metabolic diseases.

Building on this foundation, the three parties will initiate collaborative research on combined EGF/FGF therapies for key areas, including burns, dermatology, and ophthalmology. The goal is to unlock powerful therapeutic synergies, develop superior combination products and advance delivery systems, set new treatment benchmarks, and establish a leadership position in shaping this multi-billion Yuan sector.

Empowered by Academician Leadership & Platform, Creating a Fast Track from R&D to Production

The WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. In synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large-Scale Preparation, which focuses on upstream basic research, the Center has built a next-generation growth factor drug pipeline targeting multiple systems such as metabolism and dermatology. Through the ongoing research of Academician Li Xiaokun’s team, the Center has achieved internationally leading breakthroughs in key technologies, including long-acting Modification, targeted delivery, and aerosol inhalation.

The planned “Uni-Bio – WMU Joint Innovation Laboratory for Translational Medicine” will conduct in-depth research into the synergistic mechanisms of Epidermal Growth Factor (EGF) and Fibroblast Growth Factor (FGF) in regulating metabolic homeostasis, improving insulin sensitivity, and promoting tissue repair. It aims to develop novel compound formulations and drug delivery systems targeting conditions such as endocrine diseases represented by non-alcoholic steatohepatitis (NASH), respiratory diseases represented by asthma, as well as bone tissue repair. These diseases affect a large global patient population, yet there remains a significant unmet clinical need for innovative therapies. Through this collaboration, it is expected to address treatment gaps in multiple specific indications, further unlocking clinical and commercial value in the broad chronic disease market.

The “Government-University-Enterprise ” Trinity, Systematically Strengthening Full-Chain Capabilities

This collaboration extends beyond technological synergy to ecosystem co-development. The People’s Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the “China Gene Valley,” will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization.

For Uni-Bio, this tripartite cooperation delivers threefold empowerment:

  • R&D Front: Direct access to the National Engineering Research Center’s source innovation and core technologies, elevating the starting point of R&D.
  • Clinical Front: Collaboration with Wenzhou Medical University’s affiliated hospital network to accelerate clinical validation and indication expansion.
  • Commercialization Front: Leveraging the advanced manufacturing capabilities and regional policy benefits of the China Gene Valley to ensure efficient project implementation and facilitate market access.

This strategic partnership is a crucial step in the Group’s pursuit of its vision “To Be the Global Leader in Regenerative Medicine, Redefining How Science Restores and Extends Human Life” Moving forward, the Group will continue to deepen collaborations with national scientific institutions and local governments, driving the translation of more cutting-edge research into clinical and market value. This will further consolidate and enhance its comprehensive competitiveness and leadership in regenerative medicine.
Hashtag: #Uni-BioScience

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science:

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001(Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to becoming a global leader in regenerative medicine, redefining how science restores and extends human life.

About the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University:

The WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. Under the leadership of Chinese Academy of Engineering Academician Li Xiaokun, the Center has long been engaged in foundational research and novel drug discovery for cell growth factor drugs, holding a globally leading position. It brings together top-tier scientific teams, undertakes major national science and technology projects, and has successfully developed a series of innovative FGF drugs with independent intellectual property rights. Through synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large‑Scale Preparation, the Center forms a complete innovation chain from source discovery and key technological breakthroughs to industrial translation. As the important R&D engine of the China Gene Valley, it continuously promotes the incubation and translation of several original new drug candidates, including a long-acting FGF21 variant.

About the People’s Government of Ouhai District, Wenzhou:
The People’s Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the “China Gene Valley,” will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization. Through specialized industrial policies, “full-cycle escort” services, and clinical resource coordination, Ouhai District empowers the implementation and growth of innovation projects, serving as a vital driver for regional biomedical industry innovation and development.

Advertisement

Media OutReach

CP AXTRA Achieves 88/100 DJSI Sustainability Score Ranks 2nd Globally in the Food & Staples Retailing Sector, Reinforcing Its Global Leadership in Retail and Wholesale Sustainability

Published

on

BANGKOK, THAILAND – Media OutReach Newswire – 7 January 2026 – CP AXTRA Public Company Limited (CP AXTRA), the operator of Asia’s leading wholesaler and retailer “Makro and Lotus’s,” has achieved outstanding global recognition for its sustainability performance. The company earned a score of 88 out of 100 in the 2025 Corporate Sustainability Assessment (CSA) by S&P Global, which compiles the Dow Jones Sustainability Indices (DJSI). The result reflects continued significant improvement from 2023 to 2024 and elevates CP AXTRA to 2nd globally in the Food & Staples Retailing sector.

Mr. Tanin Buranamanit, Group Chief Executive Officer of CP AXTRA Public Company Limited, stated, “CP AXTRA’s score of 88 out of 100 and its 2nd place global ranking in the Food & Staples Retailing sector reflect our strong commitment to driving sustainability through concrete actions and impactful initiatives. Sustainability is embedded across our daily business operations, particularly through systematic waste management throughout the value chain to reduce environmental impact, while creating social value and operating under good corporate governance. We are also advancing toward our goals of Carbon Neutrality by 2030 and Net Zero emissions by 2050, supporting stable growth and long-term sustainable value creation.”

In 2025, CP AXTRA implemented a series of intensive environmental initiatives under the “AXTRA Zero Waste: Less Waste, More Value” concept. These efforts reduced landfill waste by more than 31,700 tonnes, including over 15,000 tonnes of food waste and more than 16,755 tonnes of recyclable waste. The Company also operated a plastic bottle take-back program through Makro and Lotus’s stores nationwide, collecting more than 2.2 million bottles. Together, these initiatives helped reduce greenhouse gas emissions by 109,649 tonnes of carbon dioxide equivalent (tCO2e), equivalent to the carbon-absorption capacity of approximately 11 million trees. CP AXTRA also expanded the use of clean energy by installing solar rooftop systems at distribution centers and more than 1,384 Makro and Lotus’s stores, alongside the rollout of a clean-energy delivery fleet of more than 300 electric vehicles, reducing environmental impacts across the value chain.

Additionally, the Company continues to strengthen its social and governance performance through employee capability development, respect for human rights, and the creation of career opportunities for farmers and SMEs nationwide under its “Platform of Opportunity” program. The initiative supports the local economy, with a combined value exceeding 30 billion baht, by connecting entrepreneurs to standardized wholesale and retail systems, generating income and long-term economic stability, and promoting equality, diversity, and fair labor practices.

The 2025 S&P Global CSA results reinforces CP AXTRA’s leadership in elevating Thailand’s wholesale and retail standards to the global level, while creating sustainable value for all stakeholders.

Hashtag: #CPAXTRA #ซีพีแอ็กซ์ตร้า #Makro #Lotuss #CPAXT #DJSI #SPGlobal #Sustainability #ESG #ขยะเป็นศูนย์ประโยชน์เป็นแสน #ลดทิ้งสร้างค่าAXTRAZeroWaste #FoodWasteManagement

The issuer is solely responsible for the content of this announcement.

About CP AXTRA Public Company Limited

CP AXTRA Public Company Limited, a subsidiary of CP Group, operates Asia’s leading wholesaler and retailer, “Makro” and “Lotus’s.’ The Company is based in Thailand, with operation across 10 countries. CP AXTRA is committed to fulfilling people’s lives with good health, love, joy, and well-being by providing solutions and meeting customers’ daily needs with technology, innovation, and operational excellence. With over 30 years of retail experience, CP AXTRA is a trusted partner for both B2B and B2C customers, offering a comprehensive range of products and services. Today, it manages over 2,700 offline stores in Thailand and Asia, with strong online presence.

Continue Reading

Media OutReach

Changhong Unveils AI‑Powered Smart Home Solutions at CES 2026

Published

on

LAS VEGAS, US – Media OutReach Newswire – 7 January 2026 – The 2026 International Consumer Electronics Show (CES 2026) opened on January 6 in Las Vegas, bringing together leading global technology companies. As the barometer of industry trends, CES highlights rapid advances in consumer electronics. This year, Changhong presented a new portfolio of AI-driven home appliances under the concept of “AI Technology + Human-Centric Design”, blending advanced intelligence with a distinctive design identity.

Changhong is accelerating the integration of AI across its home‑appliance lineup. Its panda-themed AI series merges this widely welcomed Chinese cultural symbol with AI capabilities, utilising anthropomorphic interaction, environmental sensing, and adaptive control to recreate a naturally intuitive and comforting user experience. The AI TV features the intelligent “Panda Xiaobai,” offering round-the-clock interaction. Complementing it, the AI refrigerator introduces cloud-based humidity control to maintain ingredients in an optimized freshness chamber, while the AI air conditioner delivers a gentle adaptive cooling experience reminiscent of a natural breeze. Completing the ecosystem, the AI washing machine employs triple-power cleaning for efficient fabric care. Blending everyday technology with humanistic warmth, Changhong aims to create smart home experiences that feel more intuitive and emotionally engaging.

Moreover, Changhong also unveiled several breakthroughs: The 100-inch RGB MiniLED TV, boasts an ultra-slim profile, an anti-glare display, and immersive audiovisual performance, complemented by industry-leading large-scale AI models like DeepSeek for enhanced voice interaction. The AI Air Manager 360° air conditioner extends beyond temperature control to incorporate air‑quality management, learning user habits to optimize comfort and energy efficiency. The full‑space preservation refrigerator applies AI freshness algorithms and dual‑system temperature control to eliminate odor mixing and temperature fluctuations. The AI washer‑dryer set intelligently identifies fabric types and automatically adjusts washing programs.

Changhong presents a holistic smart home ecosystem designed around user experience, further enhancing its visibility and presence in the international smart home landscape. Driven by its global “Technology + Sports” branding strategy, the brand has established an overseas network encompassing R&D, manufacturing, products, and services. Through intelligent sensing, natural interaction, and multi-scenario coordination, its AI appliances deliver a more efficient, convenient, and comfortable home experience, reflecting the Company’s forward-looking vision for smart living.

Through its fusion of AI innovation and vivid design, Changhong is shaping a distinct global brand presence, delivering smart home solutions that resonate both emotionally and technologically with users worldwide.

Hashtag: #Changhong

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

[CES 2026 Deep Dive] From Fingertips to the Stars: Lens Technology Debuts Aerospace-Grade UTG, Reshaping the LEO Satellite “Energy Canopy”

Published

on

LAS VEGAS, UNITED STATES – Media OutReach Newswire – 7 January 2026 – Amidst a CES 2026 landscape dominated by AI headlines and humanoid robots, a quiet corner of the Lens Technology booth has unexpectedly become a focal point for commercial space analysts.

There are no flashy RGB lighting effects here, only a sheet of glass as thin as a cicada’s wing, being repeatedly rolled and unrolled like a tape measure. This is the public debut of Lens Technology’s aerospace-grade UTG (Ultra-Thin Glass) photovoltaic encapsulation solution. This technology marks the official entry of the manufacturing titan—best known as a giant in the Apple supply chain—transferring its precision manufacturing capabilities from consumer electronics to humanity’s next trillion-dollar market: space infrastructure.

As leading global satellite companies begin the mass deployment of third-generation (V3) satellites, the Low Earth Orbit (LEO) internet race is entering a “second half” defined by heavy payloads, long lifespans, and low costs. Lens Technology’s entry aims to untie the knot that has long plagued the aerospace industry: the trade-off between flexibility and durability.

Farewell to the “Plastic Feel”: The Material Battle in Space

At the Lens Technology booth, engineers demonstrated the core contradiction to the audience: Traditional aerospace solar cell covers are either heavy Cerium-doped Glass (CMG) or expensive Fused Silica, typically ranging from 100μm to 500μm in thickness. They are robust, but too heavy and impossible to bend.

To adapt to the massive power demands of next-generation satellites (such as those supporting direct-to-cell services), solar wing designs are rapidly evolving from rigid panels to Roll-Out Solar Arrays (ROSA-like structures). This shift forced designers to temporarily turn to polymer materials like transparent Polyimide (CPI).

“However, polymers have a fatal weakness in space,” explained a Lens Technology on-site technical lead. “The LEO environment is filled with high-energy Atomic Oxygen (AO) and strong UV radiation. Under long-term exposure, polymer molecular chains break, causing the material to yellow, become brittle, and suffer a drastic drop in light transmission. This efficiency decay was tolerable for early satellites with 5-7 year lifespans, but for the new generation of mega-constellations pursuing higher commercial returns, it is unacceptable.”

Lens Technology’s answer is Aerospace-Grade UTG. As an inorganic material, glass possesses innate “immunity” to Atomic Oxygen and UV aging, ensuring high light transmission throughout the satellite’s lifecycle. More importantly, its dense structure provides an effective barrier against water vapor and micrometeoroids, offering physical protection for delicate ultra-thin HJT or future Perovskite batteries.

The 30-Micron “Moat”: A Perfect Match for Next-Gen Satellites

In the demo area, a piece of glass only 30μm-50μm thick is bent to an astonishing radius of R1.5mm. This level of flexibility drew gasps from the audience.

This is exactly the characteristic most coveted by top global satellite companies today. To reduce the cost per launch, next-generation mega-satellites must be stowed with origami-like efficiency inside the rocket fairing. Lens Technology’s UTG solution allows solar wings to be tightly wound like a tape measure during launch, and instantly recover to a flat state upon orbital deployment.

However, making glass thin is the first step; keeping it from shattering during the violent vibration of a rocket launch is the real challenge.

Analysts point out that Lens Technology’s core competitiveness lies in its proprietary chemical strengthening processes and laser/diamond wire cutting technologies. Glass fractures often originate from micro-cracks invisible to the naked eye. Leveraging processes honed on foldable smartphones, Lens has significantly reduced the density of micro-defects on the glass edges and surfaces. This means that even under immense tension and vibration, this “glass skin” remains tough and resilient.

Dimensional Strike: Reshaping Aerospace Costs with “Consumer-Grade” Capacity

If technical specifications are the ticket to entry, then capacity and cost control are Lens Technology’s ultimate weapons.

“The logic of commercial space has changed; it is now the era of industrial mass production,” commented an industry analyst at the scene. Compared to the small-batch, lab-grade customization model of traditional aerospace glass manufacturers, Lens Technology brings the scale of consumer electronics manufacturing.

Facing the grand ambition of global satellite leaders planning to launch tens of thousands of satellites annually, supply chain elasticity is critical. Lens Technology stated that it has the capability to rapidly expand existing pilot lines or flexibly retrofit mass production lines. This potential for “ten-thousand-satellite scale” delivery and yield control can significantly lower the BOM (Bill of Materials) cost per satellite—addressing the most sensitive pain point for commercial space giants today.

Outlook: The New Cornerstone of Next-Gen Space Energy

At CES, Lens Technology also “spoiled” its future technology roadmap.

As Perovskite/Silicon tandem cells are viewed as the mainstream for future satellite power, UTG will serve not just as a cover, but as an encapsulation substrate. Lens Technology revealed it is developing next-generation composite UTG integrated with Anti-Static (ESD) coatings and Selective Radiation coatings, which will not only protect chips from electrostatic discharge damage but also assist in regulating battery temperature.

Although this business currently accounts for a tiny fraction of Lens Technology’s massive revenue and is in a period of intensive validation with global top-tier photovoltaic component manufacturers (Tier 2) and top commercial space clients (Tier 1), its signal significance cannot be ignored.

From smartphone screens to satellite wings, Lens Technology is proving that in the era of scaled expansion for space infrastructure, ground-based industrial giants possessing extreme craftsmanship and mass manufacturing capabilities will be indispensable “pavers” for the interstellar journey.

Hashtag: #LensTechnology

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending